Business Wire

PUMA

1.9.2022 10:02:38 CEST | Business Wire | Press release

Share
Conference of the People, Powered by PUMA Puts Gen Z Voices Front and Centre

New research from PUMA, which surveyed 6,000 young people aged 18-25 from the UK, US, France, Germany, Italy and Spain has revealed that 94% of them care about the environment. At the same time, however, almost one in five aren’t motivated to help improve sustainability because the focus is always on older generations.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220901005328/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Conference of the People, powered by PUMA, is a first of its kind event which will focus on the voices of Gen Z, as the fashion industry comes together to discuss solutions towards more sustainable processes and practises. (Photo: Business Wire)

The sports company is addressing this focus with Conference of the People, powered by PUMA. The first of its kind event will centre the voices of Gen Z as the fashion industry comes together to discuss solutions towards more sustainable processes and practises. Live from London, streamed to the world on September 6th.

When asked what they would like to see brands doing more of when it comes to environment and sustainability, taking quicker action came out on top (52%). Making more commitments to change what they’re doing came next (49%), followed by communicating their goals better (40%) and being transparent with customers (34%). Two fifths of them are interested in connecting with brands to actively make the change themselves. It once again became clear that young people want brands to listen to their thoughts and opinions on the climate emergency as well. A quarter (26%) of those surveyed do not feel that there is a platform for their generation’s opinions regarding environmental sustainability. The same amount also said they want brands to create platforms to hear from younger generations.

For its one-day event, happening this month, PUMA has compiled panels that will feature some of the most prominent voices in sustainable fashion along with some famous faces that everyone will recognise, as well as next generation thinkers. Topics for discussion include tackling waste, using more sustainable materials, impacting climate change, and finding ways for the industry to collaborate to achieve results sooner.

Eco-anxiety is also on the rise amongst young people. Over a third (36%) of them admitted to feeling very anxious about global warming and the climate emergency. The number is highest in Italy (66%). The sportswear brand plans to tackle this head on. Actress, model, and activist Cara Delevingne will feature in a conversation on how young people can manage the anxieties they’re facing when it comes to the climate crisis.

Conference of the People, powered by PUMA is a first of its kind event. The aim is to create an environment for PUMA’s industry peers, activists, NGOs, experts, ambassadors, and consumers to come together and discuss solutions for some of the fashion industry’s most pressing sustainability challenges. All whilst amplifying the of voices of young people across the world.

Anne-Laure Descours, Chief Sourcing Officer at PUMA says, “With 71% of young people believing that their voices aren’t heard when it comes to environmental sustainability, it’s clear there’s a problem. Gen Z will have to live with climate decisions that are being made today, so we recognise that it’s important that they’re heard in these conversations. My hope is that through Conference of the People, we can give a platform to their voices and create a safe environment for them to collaborate with us, as an industry, on new and better ways of operating.”

To learn more about Conference of the People and to register interest in physical or virtual attendance, users can visit PUMACOP.com and follow @PUMA and [insert local IG if applicable] on social media.

Conference of the People will start on September 6 at 12pm BST (1pm CET, 7 am ET) and the livestream of the event is free to access for all.

PUMA

PUMA is one of the world’s leading sports brands, designing, developing, selling and marketing footwear, apparel and accessories. For more than 70 years, PUMA has relentlessly pushed sport and culture forward by creating fast products for the world’s fastest athletes. PUMA offers performance and sport-inspired lifestyle products in categories such as Football, Running and Training, Basketball, Golf, and Motorsports. It collaborates with renowned designers and brands to bring sport influences into street culture and fashion. The PUMA Group owns the brands PUMA, Cobra Golf and stichd. The company distributes its products in more than 120 countries, employs about 16,000 people worldwide, and is headquartered in Herzogenaurach/Germany.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220901005328/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release

Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release

Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release

The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye